“Brain Fog” after CAR T May Be Reversible

Researchers found a treatable mechanism behind the cognitive problems that can follow CAR T-cell therapy, tracing them to overactive immune cells in the brain’s white matter. In mouse models, transiently blocking microglial reactivity or inflammatory signaling reversed these brain changes and restored memory and attention function.